Prolynx
Homepage
San Francisco, United States · Founded 2010 · $70.0M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2010
- Business Model
- B2G
- Website
- prolynxinc.com
- Total Funding
- $70.0M
- Last Round
- $70.0M Series ANov 2025
- Rounds
- 1
About
ProLynx is a biotechnology company developing ultra-long-acting therapeutics for obesity and related metabolic diseases. Founded in 2010 by chemists from UCSF, the company's proprietary half-life extension platform enables once-monthly and once-quarterly dosing regimens, improving treatment adherence and tolerability compared to existing obesity drugs. Based in San Francisco, ProLynx raised a $70 million Series A in December 2025.
Summary
Prolynx is a Biotech company based in San Francisco, United States, founded in 2010. It has raised $70.0M in total across 1 round, most recently a $70.0M Series A round in Nov 2025.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/prolynx"><img src="https://indexed.vc/api/badge/company/prolynx" alt="Prolynx on Indexed.vc" width="260" height="76" /></a>